Related Experiment Video

Updated: May 13, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

Lipoprotein-associated phospholipase A2 (Lp-PLA(2)): a novel and promising biomarker for cardiovascular risks

Anping Cai1, Dongdan Zheng, Ruofeng Qiu

  • 1Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.

Disease Markers
|March 13, 2013
PubMed

Insights

Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a key biomarker for vascular inflammation and atherosclerosis. This review summarizes Lp-PLA2

Area of Science:

  • Biochemistry
  • Cardiology
  • Biomarker Discovery

Background:

  • Cardiovascular diseases (CVD) remain a leading global cause of mortality.
  • Residual cardiovascular risk persists despite current interventions.
  • Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a specific biomarker for vascular inflammation and atherosclerosis.

Purpose of the Study:

  • To review the biochemical characteristics of Lp-PLA2.
  • To summarize the role of Lp-PLA2 in atherosclerosis.
  • To discuss the clinical significance of Lp-PLA2 in risk stratification and prognosis.

Main Methods:

  • Literature review of scientific and clinical studies.
  • Analysis of data on Lp-PLA2 biochemical properties.
  • Evaluation of Lp-PLA2's correlation with cardiovascular events.

Main Results:

  • Lp-PLA2 exhibits pro-atherogenic properties and correlates with cardiovascular events.
  • Lp-PLA2 is recommended as an adjunct risk assessment tool in ATP III guidelines.
  • Darapladib, an Lp-PLA2 inhibitor, shows promising preclinical results with ongoing Phase III trials.

Conclusions:

  • Lp-PLA2 holds significant potential for cardiovascular risk stratification.
  • Therapeutic strategies targeting Lp-PLA2, like darapladib, warrant further investigation.
  • Understanding Lp-PLA2's role is crucial for managing atherosclerosis and reducing CV risk.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...